DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2. (Q35740115)
Jump to navigation
Jump to search
scientific article published on March 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2. |
scientific article published on March 2015 |
Statements
DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2 (English)
Juan Qin
Jiao Ji
Rong Deng
Jun Tang
Fen Yang
Gong-Kan Feng
Wen-Dan Chen
Xiao-Qi Wu
Xiao-Jun Qian
1 reference
1 reference